Olema Pharmaceuticals EPS OLMA

Diluted earnings per share by quarter and over the last twelve months, from 2020.

Olema Pharmaceuticals' earnings per share was −$2.12 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.61.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY26	Jun 30, 2026	−$0.61	n/a	−$2.12
Q1 FY26	Mar 31, 2026	−$0.52	n/a	−$2.02
Q4 FY25	Dec 31, 2025	−$0.50	n/a	−$1.86
Q3 FY25	Sep 30, 2025	−$0.49	n/a	−$1.81
Q2 FY25	Jun 30, 2025	−$0.51	n/a	−$1.92
Q1 FY25	Mar 31, 2025	−$0.36	n/a	−$1.95
Q4 FY24	Dec 31, 2024	−$0.45	n/a	−$2.15
Q3 FY24	Sep 30, 2024	−$0.60	n/a	−$2.19
Q2 FY24	Jun 30, 2024	−$0.54	n/a	−$2.07
Q1 FY24	Mar 31, 2024	−$0.56	n/a	−$2.02
Q4 FY23	Dec 31, 2023	−$0.49	n/a	−$2.16
Q3 FY23	Sep 30, 2023	−$0.48	n/a	−$2.32

Companies in Drug Manufacturers - General nearest Olema Pharmaceuticals' size, closest first, today.

Company	EPS, 12 months	Growth
OLMAOlema Pharmaceuticals	−$2.12
PBYIPuma Biotechnology	$0.52	−47% a year
IRWDIronwood Pharmaceuticals	$0.77
ZVRAZevra Therapeutics	$0.93
CRMDCorMedix	$2.13	+184% a year
ARVNArvinas	$0.16
COLLCollegium Pharmaceutical	$1.24	+19% a year
ABUSArbutus Biopharma	$0.78
AMPHAmphastar Pharmaceuticals	$1.70	−36% a year
OMEROmeros	$1.52
PCRXPacira BioSciences	$0.35
Peer median	$0.85